CA2724412A1 — Maintenance therapy regimen for treating acne
Assigned to Galderma Research and Development SNC · Expires 2009-11-26 · 16y expired
What this patent protects
The present invention relates to a novel maintenance therapy regimen for the treatment of acne. The novel therapy regimen follows a course of oral antibiotic therapy with a topical fixed-dose combination of a retinoid, such as adapalene, and an anti-bacterial agent, such as benzo…
USPTO Abstract
The present invention relates to a novel maintenance therapy regimen for the treatment of acne. The novel therapy regimen follows a course of oral antibiotic therapy with a topical fixed-dose combination of a retinoid, such as adapalene, and an anti-bacterial agent, such as benzoyl peroxide.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.